These are the ASX stocks I have my eye on this week. The post 5 ASX shares I'd buy with $10,000 this week appeared first on ...

Developed in collaboration with the CUHK spin-off MicroSigX Biotech Diagnostic, the world’s first “AI-Powered Multikingdom ...

Biotech software firm Tetratherix has announced the appointment of its new independent non-executive director Peter Gray, ...

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company ...

As of midyear, Maryland’s biomanufacturing footprint had a 1.1% vacancy rate, while its R&D footprint sat at 10.8% vacant, ...

The latest update is out from Moleculin Biotech ( ($MBRX) ). Moleculin Biotech, Inc. received a deficiency letter from Nasdaq on June 27, 2025, ...

US stocks closed mixed on Tuesday as the Nasdaq gained while the S&P 500 and Dow fell for a third consecutive session amid ...

Pfizer signaled Tuesday it expects a challenging 2026 as it invests in new products to offset declines in Covid-19 revenues ...

CytoAgents appointed a Chief Medical Officer and a Chief Scientific Officer two months after securing an over $2 million NIH ...

Latozinemab failure, with Nivisnebart Phase 2 data as the next key catalyst. Click here to read more about ALEC stock.

Primoris, Lyft, and Incyte could double in 2026 as earnings improve, valuations reset, and key catalysts reshape investor ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. /CNW/ — USANewsGroup.com News Commentary – Gastrointestinal cancers that once resisted checkpoint inhibitors are ...